ClinicalTrials.gov
ClinicalTrials.gov Menu

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00211952
Recruitment Status : Suspended
First Posted : September 21, 2005
Last Update Posted : September 21, 2005
Sponsor:
Collaborators:
Central and Eastern European Oncology Group
Stowarzyszenie Ludzi Wyleczonych z Raka Płuca
Pharmacia
Information provided by:
Medical University of Gdansk

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Primary Completion Date : No date given
  Study Completion Date : No date given